Cite Filings / IGC / 0001185185-26-001146
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

IGC Pharma, Inc. · Filed 2026-03-30 · Acc 0001185185-26-001146

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , igc8k033026.htm

Around this filing

  • 2026-04-20 8-K Material agreement · New debt or obligation · Unregistered share sale
  • 2026-04-06 4 Director acquired 170,000 shares (option exercise)
  • 2026-04-06 4 CEO acquired 706,409 shares (option exercise)
  • 2026-04-06 4 Director acquired 130,000 shares (option exercise)
  • 2026-04-06 4 PFO acquired 238,462 shares (option exercise)
  • 2026-03-30 8-K Other events
  • 2026-03-12 8-K Material agreement · New debt or obligation · Unregistered share sale

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading igc8k033026.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…